This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to the CDC, in 2012, 25.5% What happens when someone loses the will to live because they are tired of dealing with chronic health conditions and prescription drugs that have nasty sideeffects? How patients fare after being diagnosed with chronic illnesses depends a lot more on them than on their doctors.
The biobank will work in parallel with the MHRA’s Yellow Card website, which is used for reporting adverse events and sideeffects caused by medicines and medical devices, per the 25 May announcement. Sideeffects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.
Typically, results or new treatment prescriptions are simply uploaded to the portal with the doctors expected to give explanations during the appointment—even though the ability to provide additional information within the portal is readily available.
received FDA approval for once-daily GEMTESA—the first new oral OAB medication approved by the FDA since 2012. The treatment gap is evident: of those 30 million Americans with OAB, only 16 million have seen a doctor about the condition and only three million people are on treatment at any given time.
There was an article that examine the market for generic medicines in the Malaysia, following the introduction of the first generic patent in 2010 and the introduction of generic patent law in 2012. There are some countries in the world that do not require waiting for patent expiration to produce a generic version of a drug.
Preventing Misuse: Strict regulations are required to stop the improper use and abuse of drugs, especially those that have strong sideeffects or the potential to become addictive. Case Summary: In 2020, this company agreed to pay $678 million to settle allegations that it violated the False Claims Act by paying kickbacks to doctors.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content